Reference : Remission of severe cold agglutinin disease after Rituximab therapy.
Scientific journals : Article
Human health sciences : Anesthesia & intensive care
http://hdl.handle.net/2268/111409
Remission of severe cold agglutinin disease after Rituximab therapy.
English
LAYIOS, Nathalie mailto [Centre Hospitalier Universitaire de Liège - CHU > > Soins intensifs]
Van Den Neste, E. [> > > >]
Jost, E. [> > > >]
Deneys, V. [> > > >]
Scheiff, J. M. [> > > >]
Ferrant, A. [> > > >]
2001
Leukemia : Official Journal of the Leukemia Society of America, Leukemia Research Fund, U.K
Nature Publishing Group
15
1
187-8
Yes (verified by ORBi)
0887-6924
1476-5551
London
United Kingdom
[en] Aged ; Anemia, Hemolytic, Autoimmune/drug therapy/physiopathology ; Antibodies, Monoclonal/therapeutic use ; Antibodies, Monoclonal, Murine-Derived ; Antineoplastic Agents/therapeutic use ; Female ; Humans ; Remission Induction
http://hdl.handle.net/2268/111409

File(s) associated to this reference

Fulltext file(s):

FileCommentaryVersionSizeAccess
Restricted access
Leukemia - Remission of severe cold agglutinin disease.pdfPublisher postprint60.41 kBRequest copy

Bookmark and Share SFX Query

All documents in ORBi are protected by a user license.